Public annual accounts

ALGEMENE BOUWONDERNEMING SPRENGHERS financials

Name: ALGEMENE BOUWONDERNEMING SPRENGHERS financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for ALGEMENE BOUWONDERNEMING SPRENGHERS, with comparable measures and links to available source documents.

Company overview

Registry number

0767637115

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for ALGEMENE BOUWONDERNEMING SPRENGHERS

2025 versus 2024

Operating line: €858,710
EBITDA: €215,939
Total assets: €808,409
Equity: €25,000

EBITDA margin +25.1% · Equity ratio +3.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€858,710	€215,939	€808,409	€25,000	-
202431 Dec 2024	€592,402	€80,182	€827,758	€25,000	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€858,710

€215,939

€808,409

€25,000

202431 Dec 2024

€592,402

€80,182

€827,758

€25,000